Clinical Trials

Stomach Neoplasms

NCT05594381 2022-10-26

A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.

90 enrolled

Stomach Neoplasms

NCT05529355 2022-09-07

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

45 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05070598 2021-10-07

Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer

35 enrolled

HER2-positive Gastric Cancer

NCT03154983 2020-12-09

The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer

48 enrolled

Stomach Neoplasms

NCT04571489 2020-10-01

A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer

60 enrolled

Pancreatic Neoplasms

NCT04216758 2020-06-30

Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer

300 enrolled

Stage IA Pancreatic Adenocarcinoma

NCT04135781 2020-03-23

Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer

616 enrolled

Stomach Neoplasms

NCT04202484 2019-12-17

Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma

20 enrolled

Stomach Neoplasms

NCT03121313 2019-02-12

Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+

68 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT03475615 2018-03-23

A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites

215 enrolled

Stomach Neoplasms

NCT03175705 2018-01-18

Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCC

Phase 1 Unknown

18 enrolled

Carcinoma, Hepatocellular

NCT03204019 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

60 enrolled

Adenoma, Islet Cell

NCT03204032 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

EndocrineGastrointestinalNET

60 enrolled

Extrapancreatic Neuroendocrine Tumor

NCT02836977 2017-02-08

Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection

Phase NA Unknown

400 enrolled

Colonic Neoplasms

NCT02943252 2016-10-24

The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer

30 enrolled

Head & Neck

Head and Neck Neoplasms

NCT02623153 2015-12-07

Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer

200 enrolled

Stomach Neoplasms

NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

110 enrolled

Rectal Neoplasms

NCT00336947 2013-05-15

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

500 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01198392 2011-07-25

Trial of S-1 Plus Cisplatin in Gastric Cancer

270 enrolled

Stomach Neoplasms

NCT00209742 2010-05-26

Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer

340 enrolled

Colorectal Neoplasms

NCT00890188 2009-05-07

UFUR

34 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT00384800 2009-02-09

A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)

41 enrolled

Carcinoma, Hepatocellular

NCT00625352 2008-02-28

Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma

48 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00139971 2006-01-06

Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer

600 enrolled

Thoracic

Lung Neoplasms

NCT00037089 2005-06-24

A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer